| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/00007890-199801270-00014 |
| P698 | PubMed publication ID | 9458019 |
| P2093 | author name string | K Takahashi | |
| T Oshima | |||
| K Ito | |||
| H Kawaguchi | |||
| H Nakazawa | |||
| T Kawai | |||
| K Tanabe | |||
| K Ota | |||
| S Koga | |||
| N Ishikawa | |||
| H Toma | |||
| T Tokumoto | |||
| T Yagisawa | |||
| T Agishi | |||
| N Goya | |||
| K Sonda | |||
| S Fuchinoue | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | kidney transplantation | Q740909 |
| P304 | page(s) | 224-228 | |
| P577 | publication date | 1998-01-01 | |
| P1433 | published in | Transplantation | Q15730500 |
| P1476 | title | Long-term results of ABO-incompatible living kidney transplantation: a single-center experience | |
| P478 | volume | 65 |
| Q73846456 | A proposal for an anonymous living organ donation in Germany |
| Q39011723 | A2 to B Blood Type Incompatible Deceased Donor Kidney Transplantation in a Recipient Infected with the Human Immunodeficiency Virus: A Case Report |
| Q43632100 | ABO blood type incompatible kidney transplantation without splenectomy prepared with plasma exchange and rituximab |
| Q28236829 | ABO incompatible renal transplants: Good or bad? |
| Q36578386 | ABO-histo blood group incompatibility in hematopoietic stem cell and solid organ transplantation |
| Q46311043 | ABO-incompatible adult living donor liver transplantation for hepatocellular carcinoma |
| Q84820579 | ABO-incompatible kidney transplantation |
| Q81505608 | ABO-incompatible kidney transplantation and rituximab |
| Q44077744 | ABO-incompatible kidney transplantation using both A2 and non-A2 living donors |
| Q84647497 | ABO-incompatible kidney transplantation: first cases in Turkey |
| Q73304023 | ABO-incompatible living donor kidney transplantation under tacrolimus immunosuppression |
| Q36031039 | ABO-incompatible living donor kidney transplantation without post-transplant therapeutic plasma exchange. |
| Q44512119 | Accommodation in ABO-incompatible kidney allografts, a novel mechanism of self-protection against antibody-mediated injury |
| Q73226064 | Acute humoral rejection of kidney allografts in patients with a positive flow cytometry crossmatch (FCXM) |
| Q37686066 | Advances in immunosuppression for renal transplantation. |
| Q41650252 | Analysis of the Results of ABO-Incompatible Kidney Transplantation: In Comparison with ABO-Compatible Kidney Transplantation |
| Q37332696 | Antibody-mediated rejection: treatment alternatives and outcomes. |
| Q87149102 | Application of flow cytometry to measure anti-A/B antibody in ABO-incompatible kidney transplantation |
| Q36292000 | Assessment of variation in live donor kidney transplantation across transplant centers in the United States |
| Q37820338 | Benefits and limitations of plasmapheresis in renal diseases: an evidence-based approach |
| Q37042154 | C4d deposition without rejection correlates with reduced early scarring in ABO-incompatible renal allografts |
| Q39730018 | Clinical Outcomes and Results of Pathological Findings of 1-year Protocol Biopsy in Recipients of ABO-Incompatible Living Donor Kidney Transplantants |
| Q38163419 | Clinical efficacy of rituximab for acute rejection in kidney transplantation: a meta-analysis |
| Q100426458 | Clinical outcome of living donor kidney transplantation across simultaneous ABO and HLA incompatibility: Single center experience of first ten cases |
| Q90047669 | Clinical outcomes after ABO-incompatible renal transplantation: a systematic review and meta-analysis |
| Q38445752 | Comparative analysis of ABO-incompatible living donor kidney transplantation with ABO-compatible grafts: a single-center experience in Korea |
| Q74230704 | Comparative study of theefficacy of removal of anti-ABO and anti-gal antibodies by double filtration plasmapheresis |
| Q64098171 | Current protocols and outcomes of ABO-incompatible kidney transplantation based on a single-center experience |
| Q42169663 | Excellent outcome of ABO-incompatible living kidney transplantation under pretransplantation immunosuppression with tacrolimus, mycophenolate mofetil, and steroid |
| Q46907583 | HLA class I antibody mediated accommodation of endothelial cells via the activation of PI3K/cAMP dependent PKA pathway |
| Q38352472 | High molecular weight blood group A trisaccharide-polyacrylamide glycoconjugates as synthetic blood group A antigens for anti-A antibody removal devices. |
| Q41310063 | How to reduce lethal infectious complications in ABO-incompatible kidney transplantation |
| Q37830813 | Immunohaematological and apheretic aspects of the first kidney transplant from a living, ABO-incompatible donor carried out in Italy |
| Q74146505 | Immunohistological study on the graft following all O- and xenotransplantation in recipients with preformed antibody |
| Q42169647 | Impact of positive PRA on the results of ABO-incompatible kidney transplantation |
| Q46512795 | Improved graft survival in ABO-incompatible living donor kidney transplantation |
| Q42639376 | Improving kidney and live donation rates in Asia: living donation |
| Q77632180 | Infectious complications in ABO-incompatible living donor kidney transplantation: a single center experience |
| Q51787282 | Initial experience with ABO-incompatible live donor renal transplantation. |
| Q74616012 | Long-term follow-up of ABO-incompatible renal transplant recipients |
| Q45359031 | Long-term recurrence-free survival after liver transplantation from an ABO-incompatible living donor for treatment of hepatocellular carcinoma exceeding Milano criteria in a patient with hepatitis B virus cirrhosis: a case report |
| Q73219589 | Long-term results of living unrelated renal transplantation |
| Q52008474 | Mathematical and Experimental Analyses of Antibody Transport in Hollow‐Fiber‐Based Specific Antibody Filters |
| Q38039860 | Maximising living donation with paediatric blood-group-incompatible renal transplantation |
| Q30422315 | Mechanism of accommodation in a sensitized human leukocyte antigen transgenic murine cardiac transplant model |
| Q92996524 | New rules of ABO-compatibility in kidney transplantation |
| Q35565364 | One-year protocol biopsies from ABO-incompatible renal allografts compared with a matched cohort of ABO-compatible allografts |
| Q35822937 | Outcomes of ABO-incompatible kidney transplantation in the United States |
| Q44944396 | Plasmapheresis as preconditioning protocol in an extremely high titer ABO incompatible renal transplant (ABOiRTx) case: A new prospect for chronic kidney disease patients in India |
| Q79285293 | Plasmapheresis in renal transplant patients: a single-center experience |
| Q81574683 | Questionnaire on crossover renal transplantations in Germany |
| Q78514252 | Short-term results in ABO-incompatible living related kidney transplantation |
| Q38468859 | Short-term results of ABO-incompatible living donor kidney transplantation: comparison with ABO-compatible grafts |
| Q74605169 | Sialyl Lewis(x) monitoring as an early detector of B-cell-dependent rejection |
| Q46512790 | Successful results after 5 years of tacrolimus therapy in ABO-incompatible kidney transplantation in Japan |
| Q35925181 | Synthetic blood group antigens for anti-A removal device and their interaction with monoclonal anti-A IgM. |
| Q50857922 | The effect of different apheresis modalities on coagulation factor XIII level during antibody removal in ABO-blood type incompatible living related renal transplantation. |
| Q43533479 | Three hundred one cases of renal transplantation from Tabriz, Iran |
| Q74423367 | Transplantation of ABO group A2 kidneys from living donors into group O and B recipients |
| Q46369121 | Transplantation of ABO-incompatible and living unrelated donor-recipient combinations |
| Q84453096 | Transplantation: ABO-incompatible renal transplants: time for increased use? |
| Q42611073 | Upregulation of CD59: potential mechanism of accommodation in a large animal model |
| Q88581857 | VDJ Gene Usage of B Cell Receptors in Peripheral Blood of ABO-incompatible Kidney Transplantation Patients |
| Q47145127 | VDJ gene usage among B-cell receptors in ABO-incompatible kidney transplantation determined by RNA-seq Transcriptomic analysis |
| Q34556780 | Xenotransplantation and ABO incompatible transplantation: the similarities they share |
Search more.